Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Porwit-MacDonald

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Haematologica|April 19, 2003
Hodgkin's lymphoma in the elderly with special reference to type and intensity of chemotherapy in relation to prognosisOla Landgren, Cecilia Algernon, Ulla Axdorph, et al.
Journal of the National Cancer Institute|October 6, 2005
Family history of hematopoietic malignancy and risk of lymphomaEllen T Chang, Karin Ekström Smedby, Henrik Hjalgrim, et al.
Haematologica|June 14, 2006
The effect of allogeneic stem cell transplantation on outcome in younger acute myeloid leukemia patients with minimal residual disease detected by flow cytometry at the end of post-remission chemotherapyEdward Laane, Asa Rangert Derolf, Elisabet Björklund, et al.
International Journal of Cancer|May 19, 2005
Mantle cell lymphomas with low levels of cyclin D1 long mRNA transcripts are highly proliferative and can be discriminated by elevated cyclin A2 and cyclin B1Birgitta Sander, Jenny Flygare, Anna Porwit-Macdonald, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|September 23, 2003
Stimulation of T-cell cytokine production and NK-cell function by IL-2, IFN-alpha and histamine treatment during remission of non-Hodgkin's lymphomaRichard Ahlberg, Barbara MacNamara, Margareta Andersson, et al.
Blood|December 4, 2004
High expression of cyclin B1 predicts a favorable outcome in patients with follicular lymphomaErik Björck, Sara Ek, Ola Landgren, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 21, 2005
Cigarette smoking and risk of non-Hodgkin's lymphoma--a population-based case-control studyClaudia Schöllkopf, Karin Ekström Smedby, Henrik Hjalgrim, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|January 28, 2004
A prospective comparison of fine-needle aspiration cytology and histopathology in the diagnosis and classification of lymphomasOla Landgren, Anna Porwit MacDonald, Edneia Tani, et al.
American Journal of Epidemiology|September 30, 2005
Medication use and risk of non-Hodgkin's lymphomaEllen T Chang, Karin Ekström Smedby, Henrik Hjalgrim, et al.
Journal of the National Cancer Institute|January 5, 2006
Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtypeKarin Ekström Smedby, Henrik Hjalgrim, Johan Askling, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Haematologica|April 19, 2003
Hodgkin's lymphoma in the elderly with special reference to type and intensity of chemotherapy in relation to prognosisOla Landgren, Cecilia Algernon, Ulla Axdorph, et al.
Journal of the National Cancer Institute|October 6, 2005
Family history of hematopoietic malignancy and risk of lymphomaEllen T Chang, Karin Ekström Smedby, Henrik Hjalgrim, et al.
Haematologica|June 14, 2006
The effect of allogeneic stem cell transplantation on outcome in younger acute myeloid leukemia patients with minimal residual disease detected by flow cytometry at the end of post-remission chemotherapyEdward Laane, Asa Rangert Derolf, Elisabet Björklund, et al.
International Journal of Cancer|May 19, 2005
Mantle cell lymphomas with low levels of cyclin D1 long mRNA transcripts are highly proliferative and can be discriminated by elevated cyclin A2 and cyclin B1Birgitta Sander, Jenny Flygare, Anna Porwit-Macdonald, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|September 23, 2003
Stimulation of T-cell cytokine production and NK-cell function by IL-2, IFN-alpha and histamine treatment during remission of non-Hodgkin's lymphomaRichard Ahlberg, Barbara MacNamara, Margareta Andersson, et al.
Blood|December 4, 2004
High expression of cyclin B1 predicts a favorable outcome in patients with follicular lymphomaErik Björck, Sara Ek, Ola Landgren, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 21, 2005
Cigarette smoking and risk of non-Hodgkin's lymphoma--a population-based case-control studyClaudia Schöllkopf, Karin Ekström Smedby, Henrik Hjalgrim, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|January 28, 2004
A prospective comparison of fine-needle aspiration cytology and histopathology in the diagnosis and classification of lymphomasOla Landgren, Anna Porwit MacDonald, Edneia Tani, et al.
American Journal of Epidemiology|September 30, 2005
Medication use and risk of non-Hodgkin's lymphomaEllen T Chang, Karin Ekström Smedby, Henrik Hjalgrim, et al.
Journal of the National Cancer Institute|January 5, 2006
Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtypeKarin Ekström Smedby, Henrik Hjalgrim, Johan Askling, et al.
Pageof 3